COMPARISON OF THE METABOLISM AND ACTION OF ORAL AND TRANSDERMAL ESTRADIOL IN POSTMENOPAUSAL WOMEN

被引：0
|
作者：
SELBY, PL
MCGARRIGLE, HHG
PEACOCK, M
机构：
[1] GEN INFIRM,MRC,MINERAL METAB UNIT,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND
[2] UNIV LONDON UNIV COLL,DEPT OBSTET & GYNAECOL,LONDON WC1E 6BT,ENGLAND
来源：
JOURNAL OF ENDOCRINOLOGY | 1987年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [41] EFFECTS OF TRANSDERMAL ESTRADIOL ON SYMPTOMATIC AND PHYSIOLOGICAL-CHANGES IN POSTMENOPAUSAL WOMEN
    PEACOCK, M
    SELBY, PL
    SOUTHERN MEDICAL JOURNAL, 1987, 80 (09) : 99 - 99
  • [42] HORMONAL AND METABOLIC EFFECTS OF TRANSDERMAL ESTRADIOL/PROGESTAGEN ADMINISTRATION IN POSTMENOPAUSAL WOMEN
    PERRONE, G
    FALASCHI, P
    CAPRI, O
    PASTORE, R
    GALOPPI, P
    DURSO, R
    MARTOCCHIA, A
    ANELLI, G
    ZICHELLA, L
    INTERNATIONAL JOURNAL OF FERTILITY AND MENOPAUSAL STUDIES, 1994, 39 (04) : 202 - 207
  • [43] EFFICACY, ACCEPTABILITY, AND METABOLIC EFFECTS OF TRANSDERMAL ESTRADIOL IN THE MANAGEMENT OF POSTMENOPAUSAL WOMEN
    PADWICK, ML
    ENDACOTT, J
    WHITEHEAD, MI
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 152 (08) : 1085 - 1091
  • [44] Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations
    Devissaguet, JP
    Brion, N
    Lhote, O
    Deloffre, P
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1999, 24 (03) : 265 - 271
  • [45] Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women
    Hedrick, Richard E.
    Ackerman, Ronald T.
    Koltun, William D.
    Halvorsen, Mark B.
    Lambrecht, Lawrence J.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (01): : 132 - 140
  • [46] Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations
    J-Ph. Devissaguet
    N. Brion
    O. Lhote
    P. Deloffre
    European Journal of Drug Metabolism and Pharmacokinetics, 1999, 24 : 265 - 271
  • [47] Therapeutic dosages of oral or transdermal estradiol did not modify sCD40L levels in postmenopausal women
    Oviedo, Pilar J.
    Hermenegildo, Carlos
    Sobrino, Agua
    Tarin, Juan J.
    Cano, Antonio
    GYNECOLOGICAL ENDOCRINOLOGY, 2008, 24 (06) : 354 - 357
  • [48] Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women
    Sumino, Hiroyuki
    Ichikawa, Shuichi
    Kasama, Shu
    Takahashi, Takashi
    Kumakura, Hisao
    Takayama, Yoshiaki
    Kanda, Tsugiyasu
    Kurabayashi, Masahiko
    ATHEROSCLEROSIS, 2006, 189 (02) : 436 - 442
  • [49] Transdermal 17β-estradiol and oral 17β-estradiol plus gestodene reduce procarboxypeptidase U levels, an inhibitor of fibrinolysis, in healthy postmenopausal women
    Post, MS
    Hendriks, DF
    Van der Mooren, MJ
    Van Baal, M
    Leurs, JR
    Stehouwer, CDA
    Kenemans, P
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 578 - 578
  • [50] EFFECTS OF TRANSDERMAL 17-BETA-ESTRADIOL COMBINED WITH ORAL PROGESTOGEN ON LIPIDS AND LIPOPROTEINS IN HYPERCHOLESTEROLEMIC POSTMENOPAUSAL WOMEN
    SLOWINSKASRZEDNICKA, J
    ZGLICZYNSKI, S
    CHOTKOWSKA, E
    SRZEDNICKI, M
    STOPINSKAGLUSZAK, U
    JESKE, W
    BRZEZINSKA, A
    ZGLICZYNSKI, W
    SADOWSKI, Z
    JOURNAL OF INTERNAL MEDICINE, 1993, 234 (05) : 447 - 451
12345